AI-Powered Sugar.IQ™ Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available
Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, and its strategic technology partner, IBM (NYSE:IBM) Watson Health, today announced commercial availability of the Sugar.IQ™ smart diabetes assistant, …
AI-Powered Sugar.IQ™ Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available Read More